Titlebook: Leading Pharmaceutical Innovation; How to Win the Life Oliver Gassmann,Alexander Schuhmacher,Gerrit Reepm Book 2018Latest edition Springer

松軟

The Pipeline Challenge: How to Organize Innovation, innovation scissors.” The nature of the pipeline permits increasingly sophisticated portfolio analysis of drugs in development, offering pharma companies managerial options in managing individual drug candidates based on accessible competencies, risks, and expected benefits.

tooth-decay

The Open Innovation Challenge: How to Partner for Innovation,nge the traditional, established inhouse-only R&D paradigm. An outlook of the rise of corporate venture funds in the pharma industry illustrates how important the management and valuation of intellectual property is in the life science industry.

Cursory

The Internationalization Challenge: Where to Access Innovation,ngle of foreign R&D investors and from the perspective of indigenous Chinese players. Given the significant cost pressures in mature markets, reverse innovation in healthcare has drawn considerable attention by local governments.

阻塞

Book 2018Latest edition edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation..

連系

起皺紋

入會

Innovation: Key to Success in the Pharmaceutical Industry, pharma companies, the cost structures for pharma innovation, and the nature of the productivity gap. We describe the blockbuster imperative and the pervasive concerns about risk and safety in pharma R&D, and conclude with a brief outlook on the main themes to be discussed in the remainder of the book.

ACRID

LEVER

indenture

The Make-or-Buy Challenge: How to In- and Outsource Innovation, are discussed in detail and illustrated with cases from industry. We conclude with an example of how a breakthrough innovation can best be commercialized by a small pharma company using those make-or-buy options.